Area of research
Pharmacology · Infectious Diseases
Research interest
Research interests include Medicine, Tuberculosis, Angioedema, Hereditary angioedema, Dermatology, and Immunology.
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment
Unmet needs in hereditary angioedema: an international survey of physicians
Sex matters in <scp>CSU</scp> : Women face greater burden and poorer urticaria control, especially in midlife— <scp>CURE</scp> insights
Long-Term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions
Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
Deleterious variants in the autophagy-related gene RB1CC1/FIP200 impair immunity to SARS-CoV-2
Mucosal angioedema involving the oropharynx signals severe cold urticaria: <scp>COLD</scp> ‐ <scp>CE</scp> study insights
Sebetralstat for On‐Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT‐S
CRUSE<sup>®</sup>—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria
Non–Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry
Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A <scp>CRUSE</scp> ® mobile health study
A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema
The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
Updates in SJS/TEN: collaboration, innovation, and community
How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach
Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics
A concept for integrated care pathways for atopic dermatitis—A GA<sup>2</sup>LEN ADCARE initiative
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement
The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria—CURE Results
Adrenaline autoinjector is underprescribed in typical cold urticaria patients
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countries
Risk factors for systemic reactions in typical cold urticaria: Results from the COLD‐CE study